Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study

di Xanthopoulos, Athanasios, Bauer, Torsten T, Blum, Torsten G, Kollmeier, Jens, Schönfeld, Nicolas, Serke, Monika
Pubblicazione 2008

Pemetrexed-cisplatin with concurrent thoracic radiation after pemetrexed-cisplatin induction in patients with unresectable locally advanced non-squamous NSCLC: results by age subgr...

di Garrido, Pilar, Chouaki, Nadia, Serke, Monika, Giraud, Philippe, Ricardi, Umberto, Vallejo, Carmen, Visseren-Grul, Carla, Soldatenkova, Victoria, Novello, Silvia
Pubblicato in ESMO Open (2017)

Prognostic markers in resected large cell neuroendocrine carcinoma: a multicentre retrospective analysis

di Roesel, Christian, Welter, Stefan, Kambartel, Karl-Otto, Weinreich, Gerhard, Krbek, Thomas, Serke, Monika, Ibrahim, Mohammed, Alnajdawi, Yazan, Plönes, Till, Aigner, Clemens
Pubblicato in J Thorac Dis (2020)

65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-smal...

di Schuette, Wolfgang, Schneider, Claus-Peter, Engel-Riedel, Walburga, Schumann, Christian, Kohlhaeufl, Martin, Serke, Monika Heidi Ursel, Hoeffken, Gert, Kortsik, Cornelius, Reck, Martin
Pubblicato in Lung Cancer (Auckl) (2017)

Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients...

di Hoffknecht, Petra, Tufman, Amanda, Wehler, Thomas, Pelzer, Theo, Wiewrodt, Rainer, Schütz, Martin, Serke, Monika, Stöhlmacher-Williams, Jan, Märten, Angela, Maria Huber, Rudolf, Dickgreber, Nicolas J.
Pubblicato in J Thorac Oncol (2015)

Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab

di Villalobos, Matthias, Czapiewski, Piotr, Reinmuth, Niels, Fischer, Jürgen R., Andreas, Stefan, Kortsik, Cornelius, Serke, Monika, Wolf, Martin, Neuser, Petra, Reuss, Alexander, Schnabel, Philipp A., Thomas, Michael
Pubblicato in Oncol Lett (2019)

A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-...

di Metzenmacher, Martin, Kopp, Hans-Georg, Griesinger, Frank, Reinmuth, Niels, Sebastian, Martin, Serke, Monika, Waller, Cornelius Florian, Thomas, Michael, Eggert, Jochen, Schmid-Bindert, Gerald, Hoiczyk, Mathias, Christoph, Daniel Christian, Kimmich, Martin, Deuß, Burkhard, Seifert, Stephanie, Held, Swantje, Schuler, Martin, Herold, Thomas, Breitenbuecher, Frank, Eberhardt, Wilfried Ernst Erich
Pubblicato in Ther Adv Med Oncol (2021)

ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability

di Scheffler, Matthias, Schultheis, Anne, Teixido, Cristina, Michels, Sebastian, Morales-Espinosa, Daniela, Viteri, Santiago, Hartmann, Wolfgang, Merkelbach-Bruse, Sabine, Fischer, Rieke, Schildhaus, Hans-Ulrich, Fassunke, Jana, Sebastian, Martin, Serke, Monika, Kaminsky, Britta, Randerath, Winfried, Gerigk, Ulrich, Ko, Yon-Dschun, Krüger, Stefan, Schnell, Roland, Rothe, Achim, Kropf-Sanchen, Cornelia, Heukamp, Lukas, Rosell, Rafael, Büttner, Reinhard, Wolf, Jürgen
Pubblicato in Oncotarget (2015)

PIK3CA mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies

di Scheffler, Matthias, Bos, Marc, Gardizi, Masyar, König, Katharina, Michels, Sebastian, Fassunke, Jana, Heydt, Carina, Künstlinger, Helen, Ihle, Michaela, Ueckeroth, Frank, Albus, Kerstin, Serke, Monika, Gerigk, Ulrich, Schulte, Wolfgang, Töpelt, Karin, Nogova, Lucia, Zander, Thomas, Engel-Riedel, Walburga, Stoelben, Erich, Ko, Yon-Dschun, Randerath, Winfried, Kaminsky, Britta, Panse, Jens, Becker, Carolin, Hellmich, Martin, Merkelbach-Bruse, Sabine, Heukamp, Lukas C., Büttner, Reinhard, Wolf, Jürgen
Pubblicato in Oncotarget (2014)

Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer

di Schildhaus, Hans-Ulrich, Heukamp, Lukas C, Merkelbach-Bruse, Sabine, Riesner, Katharina, Schmitz, Katja, Binot, Elke, Paggen, Ellen, Albus, Kerstin, Schulte, Wolfgang, Ko, Yon-Dschun, Schlesinger, Andreas, Ansén, Sascha, Engel-Riedel, Walburga, Brockmann, Michael, Serke, Monika, Gerigk, Ulrich, Huss, Sebastian, Göke, Friederike, Perner, Sven, Hekmat, Khosro, Frank, Konrad F, Reiser, Marcel, Schnell, Roland, Bos, Marc, Mattonet, Christian, Sos, Martin, Stoelben, Erich, Wolf, Jürgen, Zander, Thomas, Buettner, Reinhard
Pubblicazione 2012